5 Teva Inhaler Patents Kicked Out Of Orange Book

By Andrew Karpan · June 10, 2024, 10:30 PM EDT

A New Jersey federal judge said Monday that a handful of patents covering Teva-brand asthma inhalers were "improperly listed in the Orange Book," a legal holding that U.S. Federal Trade Commission...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC et al

Case Number

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

October 06, 2023

Recent Articles By Andrew

June 26, 2024
Ga. High Court Told To Skip Inventor's 'Clerical Mistake' Fight
June 13, 2024
IP Forecast: Cooley Atty Faces DQ Bid Over Past Patent Work
May 31, 2024
Samsung Strikes First With Smart Ring IP Suit Against Oura
May 22, 2024
Inventor To Take $102M IP Malpractice Row To Ga. High Court
May 21, 2024
Sens. Challenge Pharma Lobbyist Over Patent Abuse
May 14, 2024
The PREP Immunity Question Won't Be Decided Yet
May 13, 2024
USPTO Eyes Change To Patent Applicants' Disclaimer Practice
May 08, 2024
GOP Reps. Want IP Enforcers To Get Tougher On Infringers
April 15, 2024
Hold This COVID Vax Patent Case, Judge Recommends
April 12, 2024
Trade Groups Urge Senators To Advance Patent Reform Bills